TY - JOUR
AU - U. Karsanji
AU - R. Evans
AU - J. Quint
AU - K. Khunti
AU - C. Lawson
AU - E. Petherick
AU - N. Greening
AU - S. Singh
AU - M. Richardson
AU - M. Steiner
AD - NIHR Leicester Biomedical Research Centre - Respiratory, Dept of Respiratory Sciences, College of Life Sciences, University of Leicester, Leicester, UK.
National Heart and Lung Institute, Imperial College London, London, UK.
NIHR Applied Research Collaboration East Midlands, Diabetes Research Centre, University of Leicester, Leicester, UK.
Dept of Cardiovascular Sciences, University of Leicester, Leicester, UK.
School of Sport, Exercise and Health Sciences, Loughborough University, Loughborough, UK.
AN - 36299367
BT - ERJ Open Res
C2 - PMC9589337 Institute for Health Research (NIHR)/UKRI, a speaker fee from Boehringer, support for attending meetings from Chiesi; and she is ERS Group 01.02 Pulmonary Rehabilitation Secretary (unpaid), all outside the submitted work. J.K. Quint has received grants or contracts from The Health Foundation, MRC, GSK, Bayer, BI, AUK-BLF, HDR UK, Chiesi and AZ; and payment or honoraria for lectures, presentations, speakers’ bureaus, manuscript writing or educational events from GlaxoSmithKline, Boehringer Ingelheim, AstraZeneca, Chiesi, Insmed and Bayer, all outside the submitted work. K. Khunti has received grants or contracts from Boehringer Ingelheim, AstraZeneca, Novartis, Novo Nordisk, Sanofi-Aventis, Lilly and Merck Sharp & Dohme; and payment or honoraria for lectures, presentations, speakers’ bureaus, manuscript writing or educational events from Amgen, AstraZeneca, Bayer, NAPP, Lilly, Merck Sharp & Dohme, Novartis, Novo Nordisk, Roche, Berlin-Chemie AG/Menarini Group, Sanofi-Aventis, Servier and Boehringer Ingelheim, and outside the submitted work. N.J. Greening has received grants or contracts from GlaxoSmithKline and Genentech; consulting fees from Genentech; payment or honoraria for lectures, presentations, speakers’ bureaus, manuscript writing or educational events from AstraZeneca, Chiesi and GlaxoSmithKline; and served on a Data Safety Monitoring Committee for Thirty Respiratory Limited, all outside the submitted work. M.C. Steiner has received support for the present manuscript from NIHR Applied Research Collaboration East Midlands and the NIHR Leicester Biomedical Research Centre. The remaining authors have nothing to disclose.
DO - 10.1183/23120541.00211-2022
DP - NLM
ET - 2022/10/28
LA - eng
M1 - 4
N1 - 2312-0541
Karsanji, Urvee
Orcid: 0000-0002-2376-5028
Evans, Rachael A
Orcid: 0000-0002-1667-868x
Quint, Jennifer K
Orcid: 0000-0003-0149-4869
Khunti, Kamlesh
Lawson, Claire A
Petherick, Emily
Greening, Neil J
Singh, Sally J
Richardson, Matthew
Steiner, Michael C
Journal Article
ERJ Open Res. 2022 Oct 24;8(4):00211-2022. doi: 10.1183/23120541.00211-2022. eCollection 2022 Oct.
PY - 2022
SN - 2312-0541 (Print)
2312-0541
T2 - ERJ Open Res
TI - Mortality associated with metabolic syndrome in people with COPD managed in primary care
VL - 8
ER -